Clinical Trials Directory

Trials / Completed

CompletedNCT02046941

Brain Biomarkers of Response to Treatment for Apraxia of Speech

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
VA Office of Research and Development · Federal
Sex
All
Age
40 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The study will use MRI brain imaging to identify brain changes associated in stroke patients after they receive speech-language treatment for their speech difficulties.

Detailed description

The goals of the current study are to identify grey and white matter regions that are predictive of speech treatment response and measure neural plasticity in response to speech treatment, using state-of-the-art neuroimaging and statistical processing techniques in a group of well-characterized left hemisphere patients meeting strict inclusionary criteria. Specifically, the investigators will use voxel-based lesion symptom mapping to identify lesion sites most predictive of a positive response to speech treatment and advanced diffusion imaging techniques to map changes in the integrity of white matter tracts from pre- to post-treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSpeech Production TreatmentThis treatment employs a response-contingent hierarchy made up of verbal modeling/repetition, graphic cueing, integral stimulation, and articulatory placement instruction.

Timeline

Start date
2014-03-01
Primary completion
2018-01-08
Completion
2018-06-30
First posted
2014-01-28
Last updated
2019-08-28
Results posted
2019-08-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02046941. Inclusion in this directory is not an endorsement.